BrightInsight & bioMérieux Partner for Clinical Diagnostic Digital Solutions
BrightInsight and bioMérieux announced a partnership to develop and bring to market a Clinical Digital Solution for diagnostics.
Category: Company News
Company News
Latest
Company News
Latest
FDA Approves Thermo Fisher CDx for ENHERTU Targeted NSCLC Therapy
ENHERTU is a specifically engineered HER2 directed antibody drug conjugate developed and commercialized by Daiichi Sankyo and AstraZeneca.
Company News
Latest
Avero Diagnostics Integrates with Northwest Pathology & Northwest Laboratory
Northwest Pathology announced that with its earlier acquisition of Avero Diagnostics in 2021, the company adopted the Avero Diagnostics name.
Artemis DNA Cuts Texas Operations, Shifts Focus to Oncology Portfolio in California
Global diagnostic laboratory company Artemis DNA closed its Houston, Texas facility to optimize the company’s strategy in California.
Read More
Nordic Bioscience & Roche Bolster Collab to Develop Biomarkers for Chronic Diseases
Nordic Bioscience is collaborating with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up.
Read More
Lab Data Management Platform Starts Strong in 2022
Inniti, which offers an IoT and cloud-based software platform for digitalizing lab equipment, started 2022 very strong on the sales front.
Read More
Karius Partners with Capstone Health Alliance to Widen Access of Liquid Biopsies
Karius is partnering with Capstone Health Alliance to streamline access to its test, which can rapidly detect more than 1,000 pathogens.
Read More
EKF Launches Middleware Connectivity Solution for POC Analyzers & Data Management
EKF Diagnostics launched a connectivity solution for the secure management of POC analyzers and associated data on one centralized platform.
Read More
Delfi Diagnostics Enters into Research Agreement with Cancer Center
Delfi Diagnostics has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center’s Biomarker Development Program.
Read More
Accelerate Diagnostics Gets Commercialization of Its Rapid Microbial ID System
Accelerate Diagnostics announced the commercialization of its Accelerate Arc system, which includes the Accelerate Arc Module and BC kit.
Read More
Detact Diagnostics to Set US HQ in New Hampshire
Detact Diagnostics, a Netherlands-based company that produces bacterial- and viral-detection solutions, is expanding to the U.S.
Read More
Datar Announces $250M Contract for Cancer Detection Liquid Biopsies
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read More
Innova Partners with Attomarker to Accelerate COVID Immunity Testing
Innova Medical Group formed a strategic partnership with Attomarker to expedite immunity testing for COVID and other diseases globally.
Read More
Avista Capital Completes Sale of Pathology Laboratory to Fulgent Genetics
Avista Capital Partners, a private equity firm focused on healthcare, closed on the sale of pathology laboratory Inform Diagnostics to Fulgent Genetics.
Read More
Porvair Launches High Performance Microplates for Enhanced Cell Growth & Survival
Porvair Sciences’ new Sero Krystal PDL range of coated microplates promote superior cell attachment, growth, and more, in serum-free media.
Read More
4medica & Civitas Networks for Health Partner to Improve Data Quality
4medica has partnered with Civitas Networks for Health to conduct comprehensive health data quality assessments.
Read More
CliniSys Acquired ApolloLIMS to Grow Diagnostics Capability
CliniSys has acquired ApolloLIMS to help fulfill its vision of enabling a new wave of digital diagnostics and community laboratories.
Read More
BioMérieux Acquires Specific Diagnostics
BioMérieux is set to acquire Specific Diagnostics, a company that has developed a rapid antimicrobial susceptibility test (AST) system.
Read More